DeepBiome Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $7.25M
Latest Deal Amount
  • Investors
  • 7

DeepBiome Therapeutics General Information

Description

Developer of a drug discovery platform designed to treat infections of central nervous system disorders. The company's platform leverages deep learning, microbiome and synthetic biology technologies, enabling drug companies to harness the therapeutic power of the microbiome and develop drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • One Kendall Square
  • Building 200, Suite 001
  • Cambridge, MA 02139
  • United States

DeepBiome Therapeutics Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DeepBiome Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 08-Oct-2019 $7.25M 00.00 000.00 Completed Generating Revenue
2. Accelerator/Incubator 15-Oct-2017 000 Completed Generating Revenue
1. Seed Round 01-Sep-2017 $2M $2M 000 Completed Generating Revenue
To view DeepBiome Therapeutics’s complete valuation and funding history, request access »

DeepBiome Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-III 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Seed-II 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Seed-I 4,184,099 $0.000010 $0.03 $0.55 $0.55 1x $0.55 23.24%
To view DeepBiome Therapeutics’s complete cap table history, request access »

DeepBiome Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Chengwei Luo Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Aleksandar Kostic Co-Founder & Board Member
To view DeepBiome Therapeutics’s complete executive team members history, request access »

DeepBiome Therapeutics Board Members (2)

Name Representing Role Since
Aleksandar Kostic DeepBiome Therapeutics Co-Founder & Board Member 000 0000
Jimmy Lu JD Self Board Member 000 0000
To view DeepBiome Therapeutics’s complete board members history, request access »

DeepBiome Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DeepBiome Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Baidu Ventures Corporate Venture Capital Minority 000 0000 000000 0
Heda Ventures Venture Capital Minority 000 0000 000000 0
KTB Ventures Venture Capital Minority 000 0000 000000 0
WI Harper Group Venture Capital Minority 000 0000 000000 0
Pagliuca Harvard Life Lab Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »